Showing results (41-50 of 99) with videos related to
Sort By:
Pageof 10
Leukemia & Lymphoma|October 6, 2012
The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center seriesCristina Tecchio, Federico Mosna, Angelo Andreini, et al.Medical Oncology (Northwood, London, England)|October 5, 2006
High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remissionIgnazio Majolino, Marco Ladetto, Anna Locasciulli, et al.Haematologica|April 21, 2009
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantationLucia Farina, Cristiana Carniti, Anna Dodero, et al.Hematology (Amsterdam, Netherlands)|May 17, 2013
Quality of harvest and role of cell dose in unrelated bone marrow transplantation: an Italian Bone Marrow Donor Registry-Gruppo Italiano Trapianto di Midollo Osseo StudyFranca Fagioli, Paola Quarello, Simona Pollichieni, et al.Psycho-Oncology|November 8, 2012
Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolationCristina Tecchio, Chiara Bonetto, Mariaelena Bertani, et al.Surgical Oncology|December 17, 2025
Perioperative outcomes after robotic repeat hepatectomy: A systematic reviewGianluca Cassese, Fabrizio Panaro, Fabio Giannone, et al.Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapyGiorgio Scagliotti, Makoto Nishio, Miyako Satouchi, et al.Journal of Medicinal Chemistry|February 3, 2015
Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agentUlma Cersosimo, Andrea Sgorbissa, Carmen Foti, et al.Biomed Research International|April 26, 2019
Pretransplant Nephrectomy for Large Polycystic Kidneys in ADPKD (Autosomal Dominant Polycystic Kidney Disease) Patients: Is Peritoneal Dialysis Recovery Possible after Surgery?Giuseppe Ietto, Veronica Raveglia, Elia Zani, et al.Oncotarget|June 4, 2016
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cellsAndrea Tomasella, Raffaella Picco, Sonia Ciotti, et al.Pageof 10